These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30564969)

  • 21. Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    Ko H; Shin J; Lee JE; Nam SJ; Nguyen TL; Hopper JL; Song YM
    BMC Cancer; 2017 Dec; 17(1):821. PubMed ID: 29207971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
    Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
    Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of artificial intelligence in 7533 consecutive prevalent screening mammograms from the BreastScreen Australia program.
    Waugh J; Evans J; Miocevic M; Lockie D; Aminzadeh P; Lynch A; Bell RJ
    Eur Radiol; 2024 Jun; 34(6):3947-3957. PubMed ID: 37955669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
    Evans AJ; Pinder SE; Ellis IO; Wilson AR
    J Med Screen; 2001; 8(3):149-51. PubMed ID: 11678555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
    Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
    Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
    Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
    Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.
    Buist DS; Walker R; Bowles EJ; Carney PA; Taplin SH; Onega T; Kerlikowske K; Clinton W; Miglioretti DL
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):720-7. PubMed ID: 22301831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing the impact of 25 years of DCIS treatment.
    Ozanne EM; Shieh Y; Barnes J; Bouzan C; Hwang ES; Esserman LJ
    Breast Cancer Res Treat; 2011 Aug; 129(1):165-73. PubMed ID: 21390494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-calcified ductal carcinoma in situ of the breast: comparison of diagnostic accuracy of digital breast tomosynthesis, digital mammography, and ultrasonography.
    Su X; Lin Q; Cui C; Xu W; Wei Z; Fei J; Li L
    Breast Cancer; 2017 Jul; 24(4):562-570. PubMed ID: 27837442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program.
    Weber RJ; van Bommel RM; Setz-Pels W; Voogd AC; Klompenhouwer EG; Louwman MW; Strobbe LJ; Tjan-Heijnen VC; Duijm LE
    Ann Surg Oncol; 2016 Nov; 23(12):3822-3830. PubMed ID: 27334217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
    Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ
    Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS).
    Gooch JC; Chun J; Kaplowitz E; Kurz E; Guth A; Lee J; Schnabel F
    Ann Surg Oncol; 2019 Oct; 26(11):3472-3477. PubMed ID: 31147991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
    Hofvind S; Iversen BF; Eriksen L; Styr BM; Kjellevold K; Kurz KD
    Acta Radiol; 2011 Jun; 52(5):481-7. PubMed ID: 21498306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.
    de Roos MA; van der Vegt B; de Vries J; Wesseling J; de Bock GH
    Ann Surg Oncol; 2007 Jul; 14(7):2097-104. PubMed ID: 17453296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
    Doebar SC; van den Broek EC; Koppert LB; Jager A; Baaijens MHA; Obdeijn IAM; van Deurzen CHM
    Breast Cancer Res Treat; 2016 Jul; 158(1):179-187. PubMed ID: 27318854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.